Alzheimer's & Dementia Risk Stratification CDSS
5-15 year risk stratification for Alzheimer's and related dementias in primary care
Company profile
Company profile
precision-health.ai is a Norwegian health AI company on a mission to make precision health part of routine patient care and improve health outcomes at the population level. Built on decades of research and development, the company delivers AI-powered clinical decision support (CDSS) tools for primary care physicians and specialists to address high-value clinical challenges. Their cloud-based platform integrates multimodal health data—including genetics, advanced imaging biomarkers, lab results, and electronic health records—to empower clinicians to make better informed decisions, improve outcomes, and redefine patient care. The company focuses on three primary clinical domains: neurology (Alzheimer's and dementia risk stratification and differential diagnosis), oncology (prostate cancer contouring and women's pelvic disease diagnosis), and psychiatry (cardiovascular disease risk assessment for patients with severe mental illness and medication response optimization). Developed in collaboration with practicing clinicians and researchers, precision-health.ai combines validated AI approaches with advanced imaging techniques like Restriction Spectrum Imaging (RSI) to deliver scalable diagnostic solutions. The company is actively involved in multiple EU Horizon 2020 research projects and collaborations with leading academic institutions.
Company description Precision AI Pty official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Cloud Saas deployment with recorded integration context.
Company milestones
Active participation in multiple EU Horizon 2020 projects (2023-2027): REALMENT for medication response prediction, CoMorMent for CVD risk in mental illness, and AGECare for dementia diagnosis in municipalities. Phase III RCT validation of prostate cancer contouring solution.
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
5-15 year risk stratification for Alzheimer's and related dementias in primary care
Cardiovascular risk assessment tool for patients with severe mental illnesses
Distinguish between Alzheimer's disease and different dementia subtypes at early stages
AI-powered prostate tumor contouring for precision radiation boost therapy
Predict medication response and adverse effects for mental health patients
Non-invasive AI diagnostic tool to distinguish endometriosis from ovarian cancer
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
No linked records are currently available.
Clinical validation
No linked records are currently available.
Regulatory
K251558 · 510k · Jan 12, 2026
Precision AI Surgical Planning System (PAI-SPS)K243955 · 510k · Jan 21, 2025
Precision AI Surgical Planning System (PAI-SPS)K233992 · 510k · Aug 5, 2024
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Scalable solution for primary care physicians
Radiation oncologists using RSI maps for focal boost radiation treatment
Minimize side effects and improve outcomes in shorter time for mental health patients
05 · Leadership
Leadership profiles and professional links from the current Company record.
Anders M. Dale
Founder & CEO
Ole A. Andreassen
Chief Medical Advisor
Anna C. Czerwinska
General Manager
Oleksandr Frei
Chief Technology Officer
06 · Company updates
Recent articles published on Precision AI Pty's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies providing AI-powered analytics for population health management, healthcare data integration and analysis, risk stratification, care gap identification, or value-based care analytics. Focuses on analyzing data across patient populations to improve outcomes at scale and enable data-driven decision-making across health systems.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.